Keywords: chemgenex, completes, 21m, financing, australia, pharmaceuticals, completed
ChemGenex completes A$21M financing
Article | 09 April 2007
Australia's ChemGenex Pharmaceuticals has completed an A$10.5 million ($8.6 million) capital raising achieved by a non-renounceable rights issue for 16,891,916 new shares ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
